Volume 7 Issue 6
Nov.  2016
Turn off MathJax
Article Contents
Ya-ping WANG, Rong CHEN, Shou-qing LIN, Jing-lan BAI, Ying JIANG, Ying ZHANG. Change of Uterine Size in Ovarian Aging[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(6): 401-408. doi: 10.3969/j.issn.1674-9081.2016.06.001
Citation: Ya-ping WANG, Rong CHEN, Shou-qing LIN, Jing-lan BAI, Ying JIANG, Ying ZHANG. Change of Uterine Size in Ovarian Aging[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(6): 401-408. doi: 10.3969/j.issn.1674-9081.2016.06.001

Change of Uterine Size in Ovarian Aging

doi: 10.3969/j.issn.1674-9081.2016.06.001
More Information
  • Corresponding author: CHEN Rong Tel: 010-69155012, E-mail:chenrongpumch@163.com
  • Received Date: 2016-10-28
  • Publish Date: 2016-11-30
  •   Objective  To investigate the change of uterine size in ovarian aging in women living in a Beijing community.  Methods  A total of 418 healthy women aged 30 to 68 years who could be staged by STRAW+10 staging system were recruited from a Beijing community and prospectively followed up for 5 years. Menstrual dairy was recorded daily by every woman during the research. Transvaginal ultrasonography was performed for measurement of uterine size at baseline and each year during the 5 years. Serum estradiol (E2) was tested as well.  Results  At baseline, various diameters and volume of uterus began to shrink significantly since the early post-menopausal stage+1a and shrank further at stage+1c (P < 0.05), while not changed much at late post-meno-pausal stage. The thickness of endometrium decreased from stage+1a (P < 0.05) and showed no significant change after that (P>0.05). E2 in menopausal transition and the first 2 years after menopause had a large variation that no significant difference was found comparing with reproductive stage (P>0.05). E2 level decreased significantly at stage+1c(P < 0.05) and kept at a low level at late postmenopausal stage, with no statistically significant difference compared with stage+1c (P>0.05). For women still at the same STRAW+10 stages after 5-year's follow-up, there was only decline in some diameters at early and late postmenopausal stages and no obvious change in endometrial thickness. E2 level only decreased in the late postmenopausal stage(P < 0.01). For women with stage progress after 5-year's follow-up, each line diameter and volume of the uterus changed significantly during transition to early postmenopausal stage +1a/+1b, or from menopausal transition stage to ensuing stages. Change in endometrial thickness was only found in those transformed since menopausal transition stage. E2 level changed mainly after menopausal transition stage. Uterine fibroids increased significantly during the transition from the reproductive stage to the menopausal transition stage (P < 0.01) and began to shrink after menopause but with no statistically significant difference(P>0.05). The decline in uterine volume in women with uterine fibroid was mainly observed at early postmenopausal stage, with no obvious change afterwards.  Conclusions  Uterine size, endometrial thickness, and E2 level do not change in synchronization. Uterine size shrinks during a rather long time since menopause, endometrial thickness begins to reduce mainly in the early stage after menopause. E2 in menopausal transition and the first 2 years after menopause has a big variation which does not decrease obviously until 2 years after menopause.
  • loading
  • [1] Wong JY, Gold EB, Johnson WO, et al. Circulating Sex Hormones and Risk of Uterine Fibroids:Study of Women's Health Across the Nation (SWAN)[J]. J Clin Endocrinol Metab, 2016, 101:123-130. doi:  10.1210/jc.2015-2935
    [2] Szoeke CE, Robertson JS, Rowe CC, et al. The Women's Healthy Ageing Project:fertile ground for investigation of healthy participants 'at risk' for dementia[J]. Int Rev Psychiatry, 2013, 25:726-737. doi:  10.3109/09540261.2013.873394
    [3] Freeman EW, Sammel MD, Sanders RJ. Risk of long-term hot flashes after natural menopause:evidence from the Penn Ovarian Aging Study cohort[J]. Menopause, 2014, 21:924-932. doi:  10.1097/GME.0000000000000196
    [4] 王亚平, 陈蓉, 林守清.卵巢衰老过程中血清性激素和卵巢大小的变化[J].协和医学杂志, 2016, 3:161-167. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xhyx201603001
    [5] Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages reproductive aging Workshop+10:addressing unfinished agenda of staging reproductive aging[J]. Menopause, 2012, 19:387-395. doi:  10.1097/gme.0b013e31824d8f40
    [6] 陈蓉, 林守清.构建中的生殖衰老分期——生殖衰老分期+10专题研讨会总结摘译[J].中国实用妇科与产科杂志, 2012, 28:713-715. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgsyfkyckzz201209024
    [7] Pirhonen JP, Vuento MH, Mäkinen JI, et al. Long-term effects of hormone replacement therapy on the uterus and on uterine circulation[J]. Am J Obstet Gynecol, 1993, 168:620-630. doi:  10.1016/0002-9378(93)90506-E
    [8] 林守清, 林萍, 姜玉新.绝经后卵巢和子宫萎缩及血雌二醇降低的观察[J].中国妇产科杂志, 1997, 32:524-527. http://www.cnki.com.cn/Article/CJFDTotal-ZHDB199719019.htm
    [9] 吴鸣, 沈铿, 郎景和.绝经后子宫出血与子宫内膜癌的相关因素分析[J].中华妇产科杂志, 2005, 40:487-488. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfck200507017
    [10] Committee on Gynecologic Practice, Society of Gynecologic Oncology. The American College of Obstetricians and Gynecologists Committee Opinon no.631:endometrial intraepithelial neoplasia[J]. Obstet Gynecol, 2015, 125:1272-1278. doi:  10.1097/01.AOG.0000465189.50026.20
    [11] 王良岸, 杨冬梓, 谢梅青.测量子宫内膜厚度对HRT中不规则出血的检测作用[J].实用医学杂志, 2003, 19:986-988. http://www.cnki.com.cn/Article/CJFDTotal-SYYZ200309023.htm
    [12] El Khoudary SR, McClure CK, VoPham T, et al. Longitudinal assessment of the menopausal transition, endogenous sex hormones, and perception of physical functioning:the Study of Women's Health Across the Nation[J].J Gerontol A Biol Med Sci, 2014, 69:1011-1017. doi:  10.1093/gerona/glt285
    [13] Duhan N. Current and emerging treatments for uterine myoma-an update[J]. Int J Womens Health, 2011, 3:231-241. http://www.dovepress.com/current-and-emerging-treatments-for-uterine-myoma-ndash-an-update-peer-reviewed-article-IJWH
    [14] Sabry M, Al-Hendy A. Medical treatment of uterine leiomyoma[J]. Reprod Sci, 2012, 19:339-353. doi:  10.1177/1933719111432867
    [15] Parker WH. Etiology, symptomatology, and diagnosis of ute-rine myomas[J]. Fertil Steril, 2007, 87:725-736. doi:  10.1016/j.fertnstert.2007.01.093
  • 加载中


    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索


    Article Metrics

    Article views (282) PDF downloads(8) Cited by()
    Proportional views


    DownLoad:  Full-Size Img  PowerPoint